Motco trimmed its stake in SPDR S&P Biotech (NYSEARCA:XBI) by 9.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,383 shares of the exchange traded fund’s stock after selling 1,815 shares during the period. Motco’s holdings in SPDR S&P Biotech were worth $1,475,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of XBI. Bank of New York Mellon Corp lifted its stake in shares of SPDR S&P Biotech by 1.0% in the 2nd quarter. Bank of New York Mellon Corp now owns 19,274 shares of the exchange traded fund’s stock valued at $1,488,000 after purchasing an additional 197 shares during the last quarter. Ameriprise Financial Inc. lifted its stake in shares of SPDR S&P Biotech by 32.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 110,136 shares of the exchange traded fund’s stock valued at $8,501,000 after purchasing an additional 26,752 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of SPDR S&P Biotech by 8.4% in the 2nd quarter. PNC Financial Services Group Inc. now owns 7,465 shares of the exchange traded fund’s stock valued at $576,000 after purchasing an additional 578 shares during the last quarter. Northern Trust Corp lifted its stake in shares of SPDR S&P Biotech by 68.1% in the 2nd quarter. Northern Trust Corp now owns 5,061 shares of the exchange traded fund’s stock valued at $391,000 after purchasing an additional 2,050 shares during the last quarter. Finally, FMR LLC lifted its stake in shares of SPDR S&P Biotech by 6.2% in the 2nd quarter. FMR LLC now owns 191,702 shares of the exchange traded fund’s stock valued at $14,796,000 after purchasing an additional 11,241 shares during the last quarter.

Shares of SPDR S&P Biotech (NYSEARCA:XBI) opened at $91.42 on Thursday. The stock has a market capitalization of $4,820.00 and a P/E ratio of 5.01. SPDR S&P Biotech has a one year low of $64.57 and a one year high of $97.98.

COPYRIGHT VIOLATION NOTICE: “Motco Has $1.48 Million Stake in SPDR S&P Biotech (XBI)” was originally published by Daily Political and is owned by of Daily Political. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://www.dailypolitical.com/2018/02/08/motco-has-1-48-million-stake-in-spdr-sp-biotech-xbi.html.

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with MarketBeat.com's FREE daily email newsletter.